The initiative
SteriLance Medical (Suzhou) Inc. has announced an initiative to widen collaboration with blood glucose monitoring (BGM) brands around an integrated lancing solution. The company, which makes lancing devices and lancets and develops the NanoSense brand, said the lancing step is part of the everyday testing experience because every glucose test begins with a finger prick. Its proposal is aimed at BGM manufacturers and brand owners.
What the device does
NanoSense pairs a dedicated lancing device with disposable lancets made by the company. SteriLance said routine preparation takes five steps instead of nine, and that a lancet can be loaded without removing the device cap, with the needle concealed while loading and in use. The device uses TPC motion-control technology intended to govern lancet movement and reduce vibration from end-of-stroke impact, and it has nine adjustable depth settings. It received a 2022 Red Dot Design Award.
Refill channel and cooperation terms
For meter makers, the company said, putting NanoSense into a starter kit offers a way to set the testing experience apart from first use, while the dedicated lancets open a possible refill business alongside test strips through pharmacy, e-commerce, distributor and retail channels. Cooperation could take the form of branded product integration, OEM or customised programmes, subject to partner requirements and applicable market regulations, the company said.
In the company's words
A SteriLance Medical representative said improving the blood glucose monitoring experience does not always require developing another glucose meter, and that the company aims to work with BGM brands on making the lancing process simpler through better product integration.